GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Rockwell Medical Inc.
Rockwell Medical is a biopharmaceutical company focused on treating kidney disease. Its stock price reflects its long and challenging history of commercializing its products for dialysis patients and its ongoing need for funding.
Share prices of companies in the market segment - Pharma kidney
Rockwell Medical is a biopharmaceutical company specializing in drugs for the treatment of chronic kidney disease, specifically anemia in dialysis patients. We've categorized it under "Pharma: Kidney," and the chart below shows the dynamics in this niche pharmaceutical segment.
Broad Market Index - GURU.Markets
Rockwell Medical is a biopharmaceutical company specializing in drugs for the treatment of chronic kidney disease, specifically anemia in dialysis patients. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the pharmaceutical sector.
Change in the price of a company, segment, and market as a whole per day
RMTI - Daily change in the company's share price Rockwell Medical Inc.
Rockwell Medical, Inc.'s daily stock price fluctuations reflect volatility in the kidney care sector. This metric measures the stock's sensitivity to sales of its dialysis products and regulatory announcements.
Daily change in the price of a set of shares in a market segment - Pharma kidney
Rockwell Medical, Inc. is a kidney disease treatment company. This chart shows high volatility. Comparing it to RMTI, whose revenue depends on sales of dialysis medications, helps understand its unique risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
Rockwell Medical produces drugs to treat anemia in patients with kidney disease. The pharmaceutical company's stock price is driven by sales volume and competition. These specific factors create fluctuations that contribute to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Rockwell Medical Inc.
Rockwell Medical, Inc.'s year-over-year performance tells the story of its performance in the kidney failure treatment market. Its market cap change over the past 12 months reflects its success in supplying dialysis concentrates, as well as its struggle to commercialize its Triferic, a drug that delivers iron directly to patients during dialysis.
Annual dynamics of market capitalization of the market segment - Pharma kidney
Rockwell Medical, Inc. is a biopharmaceutical company focused on treating kidney diseases. Its success depends on the commercialization of its drugs for dialysis patients. The chart shows how its niche strategy and competitive environment influence its volatile performance in the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Rockwell Medical is a biopharmaceutical company whose stock performance is driven by the success of its drug sales and progress in research. The company's business is not dependent on economic cycles. This chart reflects biotech events, not macroeconomic data.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Rockwell Medical Inc.
Rockwell Medical specializes in medications for the treatment of anemia in patients with kidney disease. Its monthly performance reflects the commercial success of its products. Quarterly reports on sales growth and profitability are key indicators of its operational effectiveness.
Monthly dynamics of market capitalization of the market segment - Pharma kidney
The market for drugs to treat kidney diseases, particularly those associated with dialysis, is an important niche in healthcare. The dynamics of this sector, shown in the graph, reflect stable demand. Companies like Rockwell Medical are providing products in this area.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Rockwell Medical, a company focused on treating kidney diseases, operates in the medical world. Its stock price is driven by drug sales and regulatory decisions, rather than general market cycles, creating a unique profile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Rockwell Medical Inc.
Rockwell Medical, which focuses on kidney disease treatments, is experiencing short-term price fluctuations, reflecting news about its medications. Sales data and market acceptance of its products for dialysis patients are the key drivers of short-term performance.
Weekly dynamics of market capitalization of the market segment - Pharma kidney
Rockwell Medical and the entire kidney care industry are responding to overall changes in Medicare rates. Government policy on dialysis is a key factor for everyone. The chart below shows how the company stacks up in this regulated market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Rockwell Medical and the entire kidney care industry are responding to overall changes in Medicare rates. Government policy on dialysis is a key factor for everyone. The chart below shows how the company stacks up in this regulated market.
Market capitalization of the company, segment and market as a whole
RMTI - Market capitalization of the company Rockwell Medical Inc.
Rockwell Medical's market cap reflects the financial valuation of a company focused on treating complications in dialysis patients. The chart reflects its struggle to commercialize its anemia treatments. Its low market cap illustrates the challenges of launching and selling new products in a conservative medical environment.
RMTI - Share of the company's market capitalization Rockwell Medical Inc. within the market segment - Pharma kidney
Rockwell Medical is a biopharmaceutical company focused on treating kidney diseases, particularly medications for dialysis patients. Its sector share reflects its position in this specialized market. The chart below shows how its weight changes based on the commercial success of its products.
Market capitalization of the market segment - Pharma kidney
Rockwell Medical specializes in medications for the treatment of anemia in dialysis patients. The chart below shows the overall market capitalization of the sector. Its dynamics reflect the needs of the vast number of patients with kidney failure. Rockwell is a key supplier in this niche.
Market capitalization of all companies included in a broad market index - GURU.Markets
Chronic kidney disease treatment is a huge market, as illustrated by the chart. Rockwell Medical supplies dialysis medications and concentrates. Its market capitalization reflects its position as a supplier of essential consumables for dialysis centers, but also the pricing pressure in this sector.
Book value capitalization of the company, segment and market as a whole
RMTI - Book value capitalization of the company Rockwell Medical Inc.
Rockwell Medical's book value is the material basis for treating patients with kidney disease. The chart reflects the value of its manufacturing facilities, where they create dialysis medications and concentrates needed to sustain the lives of millions of people.
RMTI - Share of the company's book capitalization Rockwell Medical Inc. within the market segment - Pharma kidney
Rockwell Medical produces medications for the treatment of kidney diseases. Its stake in the sector's assets lies in its dialysis concentrate production plants. This physical presence makes it a key supplier to dialysis centers, providing vital products.
Market segment balance sheet capitalization - Pharma kidney
Rockwell Medical, Inc. produces medications for the treatment of kidney diseases. Its business is moderately capital-intensive, as it requires the company to own its own manufacturing facilities. Compared to the pharmaceutical sector, this demonstrates its commitment to control over the production process.
Book value of all companies included in the broad market index - GURU.Markets
Rockwell Medical's assets are not a broad portfolio, but rather a focused production of medications for the treatment of anemia in dialysis patients. The company's balance sheet reflects the value of its production lines and distribution network. The chart shows the capital behind this key supplier to dialysis centers.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Rockwell Medical Inc.
Rockwell Medical specializes in medications for the treatment of dialysis-related kidney diseases. Its market capitalization reflects the commercial potential of its products and its ability to carve out a niche in this large and stable market.
Market to book capitalization ratio in a market segment - Pharma kidney
Rockwell Medical manufactures and markets medications for the treatment of patients with kidney disease. Its business is focused on a very specific niche. This chart shows how the market values its products and their market share compared to its manufacturing and financial assets.
Market to book capitalization ratio for the market as a whole
Rockwell Medical produces drugs for the treatment of kidney diseases, particularly anemia in dialysis patients. Its valuation depends on the success of its key products. The chart shows how the market values a pharmaceutical company with a concentrated portfolio, where value is created by intellectual property rather than manufacturing plants, relative to the overall market.
Debts of the company, segment and market as a whole
RMTI - Company debts Rockwell Medical Inc.
Rockwell Medical produces medications for the treatment of kidney diseases, particularly those associated with dialysis. Ensuring supply to clinics and developing new products requires investment in manufacturing and research. Debt financing can support the company's operational and strategic needs.
Market segment debts - Pharma kidney
Rockwell Medical, Inc. specializes in medications and products for the treatment of kidney diseases, particularly for patients on dialysis. After commercialization, the company must finance production and sales. This chart shows how the company manages its balance sheet to serve this specific and stable healthcare market segment.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Rockwell Medical Inc.
Rockwell Medical, which specializes in drugs for kidney diseases, particularly anemia in dialysis patients, incurs manufacturing and distribution costs. This chart shows its debt load. In the pharmaceutical industry, even outside the R&D stage, competition and pricing pressure from payers make high debt a risk factor.
Market segment debt to market segment book capitalization - Pharma kidney
Rockwell Medical specializes in drugs for the treatment of chronic kidney disease, specifically dialysis-associated anemia. This chart compares the company's debt to the overall market capitalization of the pharmaceutical sector. It helps assess how the company finances its niche products and ensures their availability to patients.
Debt to book value of all companies in the market
Rockwell Medical specializes in drugs for the treatment of kidney diseases, particularly those associated with dialysis. Ensuring supply and conducting clinical trials requires capital. The chart shows how the company manages its debt to support operations. A comparison with the pharmaceutical sector helps assess its financial stability in a niche market.
P/E of the company, segment and market as a whole
P/E - Rockwell Medical Inc.
For Rockwell Medical, a company focused on treating kidney disease, this chart represents the valuation of its dialysis products. The price-to-earnings ratio shows how investors assess its share of this established market. The price-to-earnings ratio reflects the company's competitive environment and its ability to commercialize its new developments.
P/E of the market segment - Pharma kidney
This chart shows the average valuation for the medical devices sector—the benchmark for Rockwell Medical. Comparing this company's valuation to the broader industry average helps understand how investors view its position in the established dialysis market and its ability to commercialize new products.
P/E of the market as a whole
Rockwell Medical specializes in medications for chronic kidney disease, specifically dialysis-associated anemia. This is a niche market with specific patient needs. This chart reflects the state of the healthcare sector. It helps understand how changes in treatment practices and reimbursement are affecting Rockwell's business and how it competes with larger pharmaceutical companies.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Rockwell Medical Inc.
Rockwell Medical specializes in medications for the treatment of chronic kidney disease, specifically anemia in dialysis patients. The company's future profitability depends on sales volumes of its medications and competition. This chart shows analysts' assessments of the kidney disease treatment market and the company's position within it.
%20P%2FE%20Rockwell%20Medical%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Rockwell-Medical-Inc.&v=1772641308093 "Chart of the company's future (projected) P/E Rockwell Medical Inc.")
Future (projected) P/E of the market segment - Pharma kidney
Rockwell Medical is a biopharmaceutical company focused on kidney disease treatment, specifically medications for dialysis patients. This chart compares its future profitability expectations with those of the pharmaceutical sector. It helps understand how the market values its medications for the treatment of anemia in dialysis patients and its concentrate business.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20kidney&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-kidney&v=1772641308168 "Future (projected) P/E graph of the market segment - Pharma kidney")
Future (projected) P/E of the market as a whole
Rockwell Medical is a biopharmaceutical company focused on kidney disease treatments. This chart shows the overall sentiment in the healthcare sector. For RMTI, the economics are less important than regulatory decisions and the ability to commercialize its products in the competitive dialysis market.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772641308281 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Rockwell Medical Inc.
Rockwell Medical is a biopharmaceutical company specializing in the treatment of kidney diseases. Its key product is designed to treat anemia in patients on dialysis. This chart shows the financial results dependent on sales of this drug and its acceptance by the medical community.
Profit of companies in the market segment - Pharma kidney
Rockwell Medical is a biopharmaceutical company focused on treating kidney disease. Its key product is designed to deliver iron to patients with chronic kidney disease on dialysis. This chart shows overall profitability in the pharmaceutical sector, demonstrating how companies are addressing specific challenges in treating chronic diseases.
Overall market profit
Rockwell Medical produces medications to treat anemia in patients with chronic kidney disease. Demand for its products is driven by medical needs and is not affected by economic cycles. The number of patients requiring dialysis is stable, providing the company with predictable revenue regardless of the economic climate.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Rockwell Medical Inc.
Rockwell Medical specializes in medications for chronic kidney disease, particularly dialysis products. Its future depends on sales of existing medications and the development of new ones. This chart shows how analysts assess its market share in dialysis medications and the potential of its product portfolio.
%20profit%20of%20the%20company%20Rockwell%20Medical%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Rockwell-Medical-Inc.&v=1772641308452 "Graph of future (projected) profit of the company Rockwell Medical Inc.")
Future (predicted) profit of companies in the market segment - Pharma kidney
Rockwell Medical specializes in medications for the treatment of chronic kidney disease, specifically anemia in dialysis patients. This chart shows forecasts for the pharmaceutical sector. Rockwell's profitability depends on the sales volume of its dialysis medications and its ability to compete with other treatment methods by offering more effective or cost-effective solutions.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20kidney&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-kidney&v=1772641308498 "Graph of future (predicted) profits of companies in a market segment - Pharma kidney")
Future (predicted) profit of the market as a whole
Rockwell Medical specializes in medications for the treatment of kidney diseases, particularly those associated with dialysis. Demand for its products is relatively stable, as they are associated with chronic conditions. However, the overall economic situation, reflected in this chart, impacts healthcare funding, which influences hospitals' drug purchases.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772641308539 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Rockwell Medical Inc.
Rockwell Medical is a biopharmaceutical company specializing in drugs for the treatment of kidney diseases, specifically anemia in dialysis patients. This chart shows how the market values its drug revenue. It reflects its market share and competition in the dialysis treatment sector.
P/S market segment - Pharma kidney
Rockwell Medical is a biopharmaceutical company specializing in the treatment of chronic kidney disease. Its key products are designed to treat anemia in dialysis patients. This chart reflects the average pharmaceutical industry valuation, helping to understand how the market views the commercial potential of Rockwell Medical's products in their specific niche.
P/S of the market as a whole
Rockwell Medical manufactures and supplies medications for the treatment of chronic kidney disease, particularly for patients on dialysis. It's a niche but stable market. This chart helps assess how the market views the company's revenue, providing life-saving medications to a vulnerable patient population.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Rockwell Medical Inc.
Rockwell Medical specializes in medications for chronic kidney disease, particularly dialysis products. This chart shows how investors estimate the company's future revenue. It reflects expectations for sales of its medications to dialysis centers, its primary customers.
%20P%2FS%20Rockwell%20Medical%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Rockwell-Medical-Inc.&v=1772641308674 "The graph of the company's future (projected) P/S Rockwell Medical Inc.")
Future (projected) P/S of the market segment - Pharma kidney
Rockwell Medical provides products for the treatment of patients with chronic kidney disease on dialysis. This chart compares the company's estimated future sales with its industry. It reflects the market's assessment of its product line and its ability to compete in the stable but concentrated dialysis market.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20kidney&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-kidney&v=1772641308689 "Future (projected) P/S market segment graph - Pharma kidney")
Future (projected) P/S of the market as a whole
Rockwell Medical is a biopharmaceutical company specializing in drugs for the treatment of chronic kidney disease. This chart reflects general expectations, and Rockwell Medical operates in a large and stable healthcare sector. Demand for its dialysis medications is supported by demographic trends and the prevalence of the disease.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772641308743 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Rockwell Medical Inc.
Rockwell Medical is a biopharmaceutical company focused on kidney disease treatments. Its revenue, shown in this chart, is generated primarily from sales of dialysis concentrates, as well as from initial sales of its new iron delivery product for dialysis patients.
Sales of companies in the market segment - Pharma kidney
Rockwell Medical specializes in the treatment of kidney diseases, producing dialysis medications and concentrates. Their products are vital for millions of patients with kidney failure. This chart shows the steady growth of the dialysis market, supported by demographic and medical factors.
Overall market sales
Rockwell Medical, Inc. specializes in medications for the treatment of chronic kidney disease. Demand for its products is relatively stable, as it depends on the number of patients. However, the growth in overall economic revenue, reflected in this chart, improves funding for the healthcare system, including the Medicare program. This ensures stable reimbursement for life-saving medications.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Rockwell Medical Inc.
Rockwell Medical, Inc. specializes in medications for chronic kidney disease, particularly dialysis products that deliver iron to patients. This chart shows analysts' expectations for demand for its medications in dialysis centers and its ability to compete in this specialized pharmaceutical market.
%20sales%20of%20the%20company%20Rockwell%20Medical%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Rockwell-Medical-Inc.&v=1772641308845 "Schedule of future (projected) sales of the company Rockwell Medical Inc.")
Future (projected) sales of companies in the market segment - Pharma kidney
Rockwell Medical is a biopharmaceutical company focused on treating kidney diseases. Its drugs target anemia associated with chronic kidney disease. This chart shows forecasts for the pharmaceutical sector, providing context for assessing the importance of the market in which Rockwell operates.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20kidney&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-kidney&v=1772641309039 "Schedule of future (projected) sales of companies in the market segment - Pharma kidney")
Future (projected) sales of the market as a whole
Rockwell Medical, which focuses on kidney disease treatment, sees this chart as a marker of the stability of the healthcare system. The robust economics reflected here ensures predictability of Medicare payments, which cover the treatment of the majority of dialysis patients, the company's primary customers.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772641309076 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Rockwell Medical Inc.
Rockwell Medical specializes in medications for the treatment of chronic kidney disease, particularly for patients on dialysis. The company's profitability depends on sales volumes to dialysis centers. This chart shows how successfully the company commercializes its therapeutic solutions and converts revenue into net profit.
Market segment marginality - Pharma kidney
Rockwell Medical specializes in medications for the treatment of chronic kidney disease, particularly those associated with dialysis. Profitability in this pharmaceutical niche depends on the efficient production and distribution of chronic medications. The chart shows how well the company competes with other nephrology solution providers.
Market marginality as a whole
Rockwell Medical is a biopharmaceutical company focused on drugs for the treatment of kidney diseases, particularly anemia in dialysis patients. Despite its overall profitability, Rockwell Medical operates in a highly specialized medical niche. Their profitability depends on sales of their drugs and reimbursement from insurance companies.
Employees in the company, segment and market as a whole
Number of employees in the company Rockwell Medical Inc.
Rockwell Medical is a biopharmaceutical company focused on treating kidney diseases. This chart shows the size of its team, which manufactures and markets medications for dialysis patients. The staff dynamics reflect its operational activities and efforts to commercialize its products.
Share of the company's employees Rockwell Medical Inc. within the market segment - Pharma kidney
Rockwell Medical specializes in medications for the treatment of chronic kidney disease, specifically anemia in dialysis patients. This chart shows the percentage of all specialists—from scientists to manufacturing personnel—that Rockwell employs in the nephrology pharmaceutical industry. This demonstrates its focus on this complex therapeutic area.
Number of employees in the market segment - Pharma kidney
Rockwell Medical is a biopharmaceutical company focused on treating kidney diseases, particularly anemia in dialysis patients. Its staff includes manufacturing and commercialization specialists. This chart shows its operational activities. Changes in staffing levels may reflect changes in demand for its products and the competitive environment.
Number of employees in the market as a whole
Rockwell Medical produces medications to treat kidney diseases, particularly anemia in dialysis patients. Demand for its products is driven by medical needs, not the economy. This chart shows general trends, but the number of patients requiring dialysis is unfortunately only growing.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Rockwell Medical Inc. (RMTI)
Rockwell Medical produces medications for dialysis patients. It's a business that combines R&D and manufacturing. This metric reflects the balance between the value of patents and the efficiency of production facilities. The graph below shows how this balance is changing.
%20of%20the%20company%20Rockwell%20Medical%20Inc.%20(RMTI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Rockwell-Medical-Inc.-RMTI&v=1772641309519 "Chart of market capitalization per employee (in thousands of dollars) of the company Rockwell Medical Inc. (RMTI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma kidney
Rockwell Medical, Inc. specializes in medications and concentrates for the treatment of kidney diseases, particularly dialysis. In the pharmaceutical industry, this metric reflects the value of a product portfolio and its market share. The chart helps understand how effectively a company commercializes its medications relative to its competitors, based on its workforce.
%20by%20market%20segment%20-%20Pharma%20kidney&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-kidney&v=1772641309535 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma kidney")
Market capitalization per employee (in thousands of dollars) for the overall market
Rockwell Medical is a biopharmaceutical company focused on treating kidney diseases, specifically anemia in dialysis patients. It is a niche medical business. This chart shows how the market values the company, whose products are aimed at improving the quality of life for a specific patient group, where both clinical efficacy and market access are important.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772641309554 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Rockwell Medical Inc. (RMTI)
Rockwell Medical specializes in medications and products for the treatment of kidney diseases, particularly for dialysis patients. It is a niche pharmaceutical and medical device company. This chart shows how efficiently the company produces and sells its specialized solutions and medications for dialysis centers.
%20Chart%20Rockwell%20Medical%20Inc.%20(RMTI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Rockwell-Medical-Inc.-RMTI&v=1772641309574 "Company Profit Per Employee (in thousands of dollars) Chart Rockwell Medical Inc. (RMTI)")
Profit per employee (in thousands of dollars) in the market segment - Pharma kidney
Rockwell Medical (RMTI) supplies medications and concentrates for the treatment of kidney disease patients on dialysis. This is a specialized medical market. This chart shows the efficiency of their operations. It reflects how successfully the company produces and supplies vital medications to dialysis centers, generating revenue per employee.
%20in%20the%20market%20segment%20-%20Pharma%20kidney&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-kidney&v=1772641309580 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma kidney")
Profit per employee (in thousands of dollars) for the market as a whole
Rockwell Medical specializes in medications and concentrates for the treatment of kidney diseases, particularly for dialysis. It is a niche pharmaceutical and medical device company. This chart shows how efficiently the company manufactures and sells its products to dialysis centers. Earnings per employee here depend on product margins and the effectiveness of the sales team.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772641309602 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Rockwell Medical Inc. (RMTI)
Rockwell Medical specializes in medications for chronic kidney disease. This graph shows how well their products are performing in dialysis centers. Increasing revenue per employee will translate into increased sales of their key medications and increased efficiency among their marketing and distribution teams.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Rockwell-Medical-Inc.-RMTI&v=1772641309637 "Sales chart per company employee Rockwell Medical Inc. (RMTI)")
Sales per employee in the market segment - Pharma kidney
Rockwell Medical specializes in the production and supply of hemodialysis products vital for patients with kidney failure. It is a medical manufacturing company. This chart shows the average revenue per employee in the sector. It helps evaluate how productive Rockwell's production lines and distribution network are compared to other dialysis solution providers.
Sales per employee for the market as a whole
Rockwell Medical, Inc. (RMTI) specializes in medications for the treatment of kidney disease, specifically anemia in dialysis patients (Triferic). This chart shows how successfully their sales team sells these niche medications to dialysis centers, generating revenue per employee.
Short shares by company, segment and market as a whole
Shares shorted by company Rockwell Medical Inc. (RMTI)
Rockwell Medical is a company focused on treating kidney disease. Its flagship product (Triferic) is intended for dialysis patients, but its adoption is very slow. The chart shows the number of investors betting that the company will fail to convince doctors and dialysis centers of the need for its drug, leading to further losses.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Rockwell-Medical-Inc.-RMTI&v=1772641309785 "Short Shares Chart for the Company Rockwell Medical Inc. (RMTI)")
Shares shorted by market segment - Pharma kidney
Rockwell Medical supplies critical consumables (concentrates) to dialysis centers. This chart shows the overall pessimism in the sector. If it rises, investors expect price pressure from large dialysis networks or the government (Medicare) to reduce the profitability of all suppliers in the industry.
Shares shorted by the overall market
Rockwell Medical supplies critical medications and concentrates for treating dialysis patients. This is a healthcare sector that should be stable. However, this chart reflects overall market pessimism. When fear is high, investors may doubt even stable sectors, especially if the company (like RMTI) has a history of financial difficulties or is highly competitive.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Rockwell Medical Inc. (RMTI)
Rockwell Medical specializes in dialysis treatments, particularly solutions for patients with kidney failure. This chart shows how investors react to sales reports or regulatory decisions. It helps identify when the stock is "overbought" (above 70) on positive news or "oversold" (below 30) on competitive concerns.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Rockwell-Medical-Inc.-RMTI&v=1772641310015 "RSI 14 indicator chart for the company's stock Rockwell Medical Inc. (RMTI)")
RSI 14 Market Segment - Pharma kidney
Rockwell Medical (RMTI) is "iron" for the kidneys. They *specialize* in drugs for the treatment of *anemia* in patients on *dialysis* (Triferic). The "Pharma kidney" sector (biotech) thrives on news. RSI\_14\_Seg shows the "temperature" of the *entire* segment. It is vital to understand: is RMTI's growth a "niche" or is *the entire* biotech "overheated"?
RSI 14 for the overall market
Rockwell Medical (RMTI) supplies dialysis medications. This chart shows that its business is "defensive." Demand for kidney failure treatments isn't dependent on euphoria or panic—it's a matter of life and death. During moments of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast RMTI (Rockwell Medical Inc.)
Rockwell Medical (RMTI) is a company specializing in kidney disease treatments, particularly dialysis products (iron delivery). This chart shows the average 12-month forecast. It reflects analyst expectations for sales of its products in dialysis centers.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-RMTI-Rockwell-Medical-Inc.&v=1772641310093 "A chart showing analyst consensus forecasts for the expected stock price. RMTI (Rockwell Medical Inc.)")
The difference between the consensus estimate and the actual stock price RMTI (Rockwell Medical Inc.)
Rockwell Medical (RMTI) is a company that supplies dialysis concentrates (consumables) and develops medications to treat anemia in dialysis patients. This chart shows their "pivot" estimate. It measures the gap between the price and the consensus target, reflecting whether analysts believe they can monetize their medications.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-RMTI-Rockwell-Medical-Inc.&v=1772641310108 "A chart showing the difference between the consensus forecast and the actual stock price. RMTI (Rockwell Medical Inc.)")
Analyst consensus forecast for stock prices by market segment - Pharma kidney
Rockwell Medical is a company focused on treating kidney disease. It supplies dialysis supplies and has developed a drug (Triferic) for delivering iron to patients. This chart shows analysts' overall expectations for the kidney pharmaceutical sector. It reflects whether experts believe the dialysis market will grow.
Analysts' consensus forecast for the overall market share price
Rockwell supplies dialysis products for kidney failure. This chart, showing the collective market outlook, is key. While dialysis is "defensible," RMTI is a small-cap growth story. When analysts are pessimistic ("risk-off"), investors prefer the safety of blue chips (like DaVita) to small-cap growth stories.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Rockwell Medical Inc.
Rockwell Medical is a pure-play player in dialysis. They don't make machines; they manufacture and supply critical consumables (hemodialysis concentrates, iron) for clinics treating kidney failure. This chart is a summary indicator of their razor blades and blades. It reflects their ability to win contracts with dialysis centers (DaVita, Fresenius) to supply their consumables.
AKIMA Market Segment Index - Pharma kidney
Rockwell Medical (RMTI) is a biopharmaceutical company specializing in the treatment of kidney diseases. They manufacture and supply dialysis products, including iron supplements, to clinics across the country. The chart shows the average index for the segment. It helps investors assess how well Rockwell Medical performs in its niche compared to the pharmaceutical industry average.
The AKIM Index for the overall market
Rockwell Medical is a biopharmaceutical company producing dialysis concentrates and a key supplier to clinics. This chart, which reflects the market average, provides a macro backdrop. It helps assess how RMTI, as it stabilizes its business and strives for profitability, compares to overall economic trends in healthcare.
